Related Experiment Video

Updated: Dec 7, 2025

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model
09:03

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model

Published on: October 16, 2017

9.0K

VAV1 mutations contribute to development of T-cell neoplasms in mice

Kota Fukumoto1, Mamiko Sakata-Yanagimoto1,2,3, Manabu Fujisawa2

  • 1Department of Hematology, Comprehensive Human Biosciences, and.

Blood
|September 29, 2020
PubMed

Insights

Activating Vav guanine nucleotide exchange factor 1 (VAV1) mutations promote T-cell neoplasms (TCNs) by impairing p53 and activating Myc pathways. VAV1 mutations drive malignant T-cell transformation, offering a model for TCN therapeutic target discovery.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Activating mutations in VAV1 are found in T-cell neoplasms (TCNs).
  • The precise oncogenic role of VAV1 mutations in TCNs remains incompletely understood.
  • Understanding VAV1's role is crucial for developing targeted therapies for TCNs.

Purpose of the Study:

  • To elucidate the oncogenic functions of VAV1 mutations in T-cell malignant transformation.
  • To establish a preclinical model for studying TCNs with VAV1 mutations.
  • To identify potential therapeutic strategies for VAV1-mutated TCNs.

Main Methods:

  • Generated transgenic mice expressing human TCN-derived VAV1 mutants.
  • Utilized p53-null backgrounds to accelerate tumor development.
  • Performed whole-transcriptome analysis and Myc locus amplification studies.
  • Assessed therapeutic efficacy using JQ1, a Myc pathway inhibitor.

Main Results:

  • VAV1 mutations cooperate with p53 loss to induce TCNs, with shorter latency and increased maturation.
  • Transplanted VAV1-mutant cells demonstrated cell-autonomous tumor-initiating capacity.
  • TCNs exhibited enrichment of Myc-related pathways and recurrent Myc locus amplification.
  • JQ1 treatment significantly prolonged survival in tumor-bearing mice.

Conclusions:

  • VAV1 mutations are key drivers of T-cell malignant transformation in vivo, particularly in a p53-deficient context.
  • The VAV1-mutant mouse model effectively recapitulates mature TCNs, including PTCL-GATA3.
  • Targeting the Myc pathway shows promise for treating VAV1-mutated TCNs, validating this model for drug screening.

More Related Videos

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

12.6K
Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

10.8K

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.9K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K